Mandatory notification regarding exercise and trade of subscription rights and trade of shares NewsKristin EivindvikDecember 21, 2016
Update on the existing pre-clinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikDecember 13, 2016
PCI Biotech and eTheRNA immunotherapies initiate research collaboration NewsKristin EivindvikDecember 8, 2016
Notice to the extraordinary general meeting to resolve a fully underwritten Rights Issue of NOK 70 million NewsKristin EivindvikNovember 17, 2016
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 70 million NewsKristin EivindvikNovember 17, 2016
PCI Biotech to present poster at the ESMO Symposium on Immuno-Oncology 2016 NewsKristin EivindvikNovember 4, 2016
Results from the bile duct cancer study will be presented as late-breaking news at United European Gastroenterology Week NewsKristin EivindvikOctober 17, 2016
PCI Biotech to present poster at the Second International Cancer Immunotherapy Conference NewsKristin EivindvikSeptember 23, 2016
PCI Biotech to present phase I results at Nordic Life Science Days 2016 NewsKristin EivindvikSeptember 13, 2016
Independent evaluation confirms early promising signs of efficacy in the phase I/II bile duct cancer study NewsKristin EivindvikSeptember 6, 2016
PCI Biotech and BioNTech initiates preclinical research collaboration NewsKristin EivindvikSeptember 1, 2016
